No impact of increasing symptoms on quality of life? Longitudinal data from the German MALIFE-Project on patients receiving monochemo- and endocrine treatment for advanced breast cancer – results from the TMK registry group.

Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015.

The Breast 24 (suppl3) (OR51), 39. doi:10.1016/S0960-9776(15)30063-1

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2015; Veranstaltung: ABC3; Journal: The Breast

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com